Featured Research

from universities, journals, and other organizations

Public support for HPV vaccine wanes when linked to controversy, study finds; Public opinion about other vaccines remains unchanged

Date:
November 6, 2010
Source:
University of Minnesota
Summary:
In a new paper, researchers found that attendant controversy resulted in diminished public support for legally mandating the HPV vaccine.

The vaccine that protects against the potentially cancer-causing human papillomavirus (HPV) enjoys wide support in the medical and public health communities. Yet state laws to require young girls to be vaccinated as a requirement for middle school attendance have aroused controversy with parents, politicians, and even medical and public health experts disagreeing about whether such laws are appropriate. News coverage about HPV vaccine requirements tends to amplify this controversy, possibly leading to negative attitudes among the public about the value of the HPV vaccine or even about other vaccines.

In a paper published in the November issue of the journal Health Affairs, University of Minnesota School of Public Health researcher Sarah Gollust and colleagues found that attendant controversy resulted in diminished public support for legally mandating the HPV vaccine.

Gollust and colleagues administered an Internet-based survey to a randomly selected sample of participants that was representative of the U.S. population. Participants were assigned to two groups who were then exposed to two different hypothetical news briefs about legislative action related to the HPV vaccine: one that presented the HPV vaccine as enjoying widespread support and the other positioning the vaccine as controversial.

The study is the first of its kind to examine directly the tie between controversy about a piece of health policy portrayed in the news media and public support for the policy. Based on this study and previous research, the researchers suggest that prolonged exposure to controversy has the potential to erode public support for the policy.

"This research raises important questions about how the news media's tendency to report on controversy shapes public opinion about health policy," says Gollust.

Researchers also found that while support for HPV vaccine legislation waned in the shadow of controversy, support for other vaccines remained unchanged, an encouraging finding, according to Gollust. Some public health experts have worried that publicized controversy over the HPV vaccine could lead to public concerns about other childhood vaccines, a particularly important issue because of recent outbreaks of vaccine-preventable diseases like whooping cough and measles.

This research project was supported in part by the Robert Wood Johnson Foundation and the National Science Foundation.


Story Source:

The above story is based on materials provided by University of Minnesota. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. E. Gollust, A. F. Dempsey, P. M. Lantz, P. A. Ubel, E. F. Fowler. Controversy Undermines Support For State Mandates On The Human Papillomavirus Vaccine. Health Affairs, 2010; 29 (11): 2041 DOI: 10.1377/hlthaff.2010.0174

Cite This Page:

University of Minnesota. "Public support for HPV vaccine wanes when linked to controversy, study finds; Public opinion about other vaccines remains unchanged." ScienceDaily. ScienceDaily, 6 November 2010. <www.sciencedaily.com/releases/2010/11/101103135342.htm>.
University of Minnesota. (2010, November 6). Public support for HPV vaccine wanes when linked to controversy, study finds; Public opinion about other vaccines remains unchanged. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2010/11/101103135342.htm
University of Minnesota. "Public support for HPV vaccine wanes when linked to controversy, study finds; Public opinion about other vaccines remains unchanged." ScienceDaily. www.sciencedaily.com/releases/2010/11/101103135342.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) — The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) — Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) — A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) — The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins